stars 1 stars 2 stars 3

In May of 2012, CryoLife acquired Hemosphere, Inc. Hemosphere manufactures the HeRO® (Hemodialysis Reliable Outflow) Graft, which is a vascular access device for use in hemodialysis for patients with end-stage renal disease. The HeRO Graft is the ONLY fully subcutaneous AV access solution clinically proven to maintain long term access for hemodialysis patients with central venous stenosis.

Hemosphere, Inc. Questions

The Hemosphere, Inc. annual revenue was $2 million in 2026.

4 people are employed at Hemosphere, Inc..

Hemosphere, Inc. is based in Kennesaw, Georgia.

The NAICS codes for Hemosphere, Inc. are [62, 621].

The SIC codes for Hemosphere, Inc. are [384, 38].

Top Hemosphere, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users